Pharma & Biotech
The gene therapy group will list on the Nasdaq Global Select Market on Friday with its shares priced at...
08.52 Fri 07 Aug 2020
Incanthera eyes huge market for cancer-prevention suncream
Imugene presents HER2 immuno-oncology vaccines success at ESMO ahead of 2020 studies
ImmuPharma targets regulatory approval as follow-up study confirms “outstanding” safety profile of Lupuzor
Only registered members can use this feature.
© Proactive Investors 2019.
Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority. Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.